This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: The Innovations of Harvey M Higgins, Jr.
Introduction
Harvey M Higgins, Jr. is a notable inventor based in Danville, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on antibiotics. His innovative approach has led to the development of a new glycopeptide antibiotic that shows promise in combating bacterial infections.
Latest Patents
Higgins holds a patent for Antibiotic M43A, a pharmaceutical composition and method of use. Antibiotic M43A is produced by Nocardia orientalis strains NRRL 2450 and NRRL 2452. This antibiotic exhibits excellent antibacterial activity that is comparable to that of vancomycin. His patent portfolio includes 1 patent.
Career Highlights
Higgins has had a distinguished career at Eli Lilly and Company, where he has been involved in groundbreaking research and development. His work has contributed to advancements in antibiotic therapies, showcasing his commitment to improving public health through innovative solutions.
Collaborations
Throughout his career, Higgins has collaborated with esteemed colleagues, including Kurt E Merkel and Mack H McCormick. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.
Conclusion
Harvey M Higgins, Jr. is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to antibiotic development. His work continues to impact the field positively, demonstrating the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile